Nathaniel Lizak

Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

Shelagh B. Coutts, Sandeep Ankolekar, Ramana Appireddy et al. · The Lancet · 2024 · 125 citations · Full text

Medicine, Neurology, Cerebrovascular Surgery +11

Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study

Frederike Cosima Oertel, Joachim Havla, Adriana Roca‐Fernández et al. · Journal of Neurology Neurosurgery & Psychiatry · 2018 · 115 citations · Full text

Medicine, Neurology, Ophthalmology +17

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

Nathaniel Lizak, Alessandra Lugaresi, Raed Alroughani et al. · Journal of Neurology Neurosurgery & Psychiatry · 2016 · 58 citations · Full text

Life Sciences, Immunology, Neurology +16

Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudy

Nathaniel Lizak, Suzanne Hodgkinson, Ernest Butler et al. · Multiple Sclerosis Journal · 2020 · 45 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis

Nathaniel Lizak, Charles B. Malpas, Sifat Sharmin et al. · JAMA Neurology · 2020 · 35 citations · Full text

Medicine, Neurology, Disability Management +8